Skip to main content
Premium Trial:

Request an Annual Quote

Patent Watch: Mar 20, 2009

Premium

Cyntellect has been awarded US Patent 7,505,618, "Method and apparatus for selectively targeting specific cells within a cell population."

The inventors listed on the patent are Bernhard Palsson, Manfred Koller, and Timothy Eisfeld.

As stated in its abstract, the patent provides a method and apparatus for selectively identifying, and targeting with an energy beam, specific cells within a cell population, for the purpose of inducing a response in the targeted cells. The present invention can identify and affect every detectable cell in a population, without substantially affecting non-targeted cells within the mixture.


The University of Michigan has been awarded US Patent 7,504,234, "Assays for S-adenosylmethionine (AdoMet)-dependent methyltransferase activity."

The inventors listed on the patent are Raymond Trievel, Evys Collazo-Santiago, and Jean-Francois Couture.

The patent relates to coupled enzyme assays, according to its abstract. In particular, the patent provides a coupled fluorescent assay for detection of S-adenosylmethionine-dependent methyltransferase activity and S-adenosylhomocysteine hydrolase enzyme activity.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.